U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
158911158911A Phase II Trial of TPI 287 in Patients With Metastatic Prostate CancerTerminatedNo Results AvailableProstate CancerDrug: TPI 287|Drug: TPI 287https://ClinicalTrials.gov/show/NCT00479635
158912158912Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus ErythematosusTerminatedNo Results AvailableSystemic Lupus ErythematosusDrug: TRU-015https://ClinicalTrials.gov/show/NCT00479622
158913158913Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 DiabetesRecruitingNo Results AvailableMetabolic SyndromeDrug: Transdermal testosterone therapy|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00479609
158914158914This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.RecruitingNo Results AvailableOveractive BladderDrug: Botoxhttps://ClinicalTrials.gov/show/NCT00479596
158915158915Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOXCompletedNo Results AvailableCancerDrug: BMS-690514 / FOLFIRI|Drug: BMS-690514 / FOLFOXhttps://ClinicalTrials.gov/show/NCT00479583
158916158916Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.CompletedNo Results AvailableFemale Sexual DysfunctionDrug: PF-00446687|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00479570
158917158917Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer DiseaseBiological: ACC-001 + QS-21|Biological: ACC-001|Biological: QS-21|Drug: Placebo: Phosphate buffered salinehttps://ClinicalTrials.gov/show/NCT00479557
158918158918Sequential Compression Devices for Treatment of Restless Legs SyndromeCompletedNo Results AvailableRestless Legs SyndromeDevice: AirCast Sequential Compression Devicehttps://ClinicalTrials.gov/show/NCT00479531
158919158919Prognostic Value of Cardiac and Renal Markers in Ischemic Stroke and Transient Ischemic AttackRecruitingNo Results AvailableIschemic Stroke|Transient Ischemic Attackhttps://ClinicalTrials.gov/show/NCT00479518
158920158920Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive BladderCompletedNo Results AvailableUrinary Bladder, OveractiveDrug: UK-369,003|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00479505
158921158921Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, VolunteersCompletedNo Results AvailableObesityDrug: CP-866,087|Drug: CP-866,087|Drug: CP-866,087|Drug: placebohttps://ClinicalTrials.gov/show/NCT00479492
158922158922Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor DevelopmentCompletedNo Results AvailableVitamin B 12 DeficiencyDrug: Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)https://ClinicalTrials.gov/show/NCT00479479
158923158923Dose-Range Finding Study for MK0893 (0893-008)TerminatedHas ResultsDiabetes Mellitus, Type 2Drug: MK0893|Drug: Metformin|Drug: Placebo to MK0893|Drug: Placebo to Metforminhttps://ClinicalTrials.gov/show/NCT00479466
158924158924Lilly's Emotional and Physical Symptoms of DepressionCompletedNo Results AvailableMajor Depressive DisorderDrug: duloxetine hydrochloridehttps://ClinicalTrials.gov/show/NCT00479453
158925158925Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy AdultsCompletedNo Results AvailableAlzheimer DiseaseDrug: SAM-315https://ClinicalTrials.gov/show/NCT00479440
158926158926A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With OsteoarthritisCompletedNo Results AvailableOsteoarthritisDrug: GW842166https://ClinicalTrials.gov/show/NCT00479427
158927158927Lilly's Emotional and Physical Symptoms of Depression StudyCompletedNo Results AvailableMajor Depressive DisorderDrug: Duloxetine hydrochloridehttps://ClinicalTrials.gov/show/NCT00479414
158928158928Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD PatientsCompletedHas ResultsEarly Parkinson Disease (Early PD)Drug: Pramipexol Extended Release|Drug: Pramipexol Immediate Release|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00479401
158929158929Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)CompletedHas ResultsPrimary Hypercholesterolemia|Mixed DyslipidemiaDrug: Comparator: simvastatin|Drug: niacin (+) laropiprant|Drug: Comparator: atorvastatin calciumhttps://ClinicalTrials.gov/show/NCT00479388
158930158930Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer ScreeningCompletedNo Results AvailableCervical Cancer|Cervical Intraepithelial NeoplasiaProcedure: Adding Human Papillomavirus testing to organised cervical screeninghttps://ClinicalTrials.gov/show/NCT00479375
158931158931Anticoagulant Therapy During Pacemaker ImplantationCompletedNo Results AvailableHemorrhage|Thrombosis|EmbolismDrug: Warfarin|Drug: Aspirin|Device: Permanent pacemaker|Device: Implantable Cardioverter-defibrillatorhttps://ClinicalTrials.gov/show/NCT00479362
158932158932Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531CompletedNo Results AvailableAlzheimer DiseaseDrug: SAM-531https://ClinicalTrials.gov/show/NCT00479349
158933158933A Dose-defining Study of OPC-41061 in Treatment of Hepatic EdemaCompletedHas ResultsCirrhosisDrug: OPC-41061 7.5mg|Drug: OPC-41061 placebo|Drug: OPC-41061 15mg|Drug: OPC-41601 30mghttps://ClinicalTrials.gov/show/NCT00479336
158934158934Pneumococcal Reference StandardCompletedNo Results AvailablePneumococcal InfectionsBiological: Pneumovax 23https://ClinicalTrials.gov/show/NCT00479323
158935158935Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head LiceCompletedNo Results AvailableHead LiceDrug: Summers 5% L.A.https://ClinicalTrials.gov/show/NCT00479310
158936158936Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese MalesCompletedNo Results AvailableAlzheimer DiseaseDrug: SAM-531https://ClinicalTrials.gov/show/NCT00479297
158937158937Efficacy of Average Volume Assured Pressure Support With Bi-Level Pressure Support Nocturnal VentilationCompletedNo Results AvailableChronic Hypercapnic Respiratory Failure|Obesity Hypoventilation Syndrome|Chronic Obstructive Pulmonary DiseaseProcedure: Average volume assured pressure support (AVAPS)https://ClinicalTrials.gov/show/NCT00479284
158938158938Evaluating the Effectiveness of a Community Based Intervention for Persons With Dementia and Their Caregivers in a Developing CountryCompletedNo Results AvailableDementia|Behavioral Symptoms|Mental HealthBehavioral: Home based, flexible, stepped care intervention|Behavioral: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period.https://ClinicalTrials.gov/show/NCT00479271
158939158939Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And AdolescentsTerminatedHas ResultsDiabetes Mellitus, Type 1Drug: Inhaled insulin (Exubera)|Drug: Subcutaneous Insulin (subject's prescribed)https://ClinicalTrials.gov/show/NCT00479258
158940158940WHODAS-II for Patients With Nonspecific Low Back PainTerminatedNo Results AvailableLow Back PainOther: Set of questionnaires (respondent)https://ClinicalTrials.gov/show/NCT00479245

* Görseller ve İçerik tekif hakkına sahip olabilir